ulipristal acetate (Ella)
Jump to navigation
Jump to search
Introduction
FDA-approved Aug 2010, available only by prescription
Indications
- emergency contraceptive (plan B)
- for use within 120 hours (5 days) after failure of standard contraception or after unprotected intercourse
- hemorrhage due to uterine fibroids[4]
Dosage
- single tablet 30 mg
Storage
Adverse effects
- headache (9%)
- nausea (9%)
- abdominal pain (7%)
- dysmenorrhea
- fatigue
- dizziness
Mechanism of action
- progesterone agonist/antagonist that works mainly by inhibiting or delaying ovulation
More general terms
More specific terms
References
- ↑ Glasier AF et al Ulipristal acetate versus levonorgestrel for emergency contraception: A randomised non-inferiority trial and meta- analysis. Lancet 2010 Feb 13; 375:555. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20116841
- ↑ FDA NEWS RELEASE, August 13, 2010 FDA approves ella <TM> tablets for prescription emergency contraception http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm222428.htm
- ↑ Prescriber's Letter 17(10): 2010 Ella (Ulipristal) for Emergency Contraception Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=261008&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 4.0 4.1 Donnez J et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012 Feb 2; 366:409. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22296075
Donnez J et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 2012 Feb 2; 366:421. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22296076
Stewart EA. Uterine fibroids and evidence-based medicine-Not an oxymoron. N Engl J Med 2012 Feb 2; 366:471. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22296082 - ↑ 5.0 5.1 Prescriber's Letter 21(6): 2014 Oral Meds to Keep in Original Containers Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=300622&pb=PRL (subscription needed) http://www.prescribersletter.com